LYMErix™, the only Lyme Disease vaccine, was pulled from the market in February 2002.  The manufacturer, GlaxoSmithKline PLC, claimed that there was not enough demand to justify the continued manufacture and marketing of the vaccine.
The following links provide additional information on Lyme Disease
American Lyme Disease Foundation Arthritis Foundation Centers for Disease Control and Prevention Infectious Disease Society of America National Institutes of Health	Time Table of Lyme Disease    1975 First Lyme Disease case reported (Lyme, Connecticut)  1981 Microbe identified  1989 OspA (an outer surface protein) found and cloned  early 1990s OspA antibodies found in many patients with chronic Lyme disease  1990-92 Vaccinations with rOspA found to protect mice against Lyme disease infections  1992-95 Vaccinations with rOspA tested in other animals  1995 Lyme vaccine found safe and effective in persons with Lyme disease  1995-98 Vaccine found safe and effective in people without Lyme disease  1998 FDA approved Lyme vaccine  2002 Manufacturer pulls vaccine from the market   adapted from NIAID Lyme Disease website
This page was last updated on February 08, 2012 © 2010 Institute for Vaccine Safety